New York - Paul Hastings LLP, a leading global law firm, announced today that veteran life sciences consultant BJ D’Avella has joined the firm to lead the creation of a new Life Sciences Consulting Group. D’Avella, who was previously with Deloitte, will serve as Group Leader of a team of life sciences consultants. They will collaborate with the lawyers in Paul Hastings’ leading Life Sciences practice to offer clients a one-stop shop.
“The landscape is changing, and we are constantly thinking about innovative ways we can help our clients,” said Gary Giampetruzzi, global chair of the Life Sciences practice at Paul Hastings. “BJ’s arrival, and the formation of this consulting team, continues Paul Hastings’ long track record of offering clients creative, value-added services. With the establishment of this team we will be able to help our life sciences clients with the full range of their legal, compliance, and execution needs. We will be uniquely positioned in the marketplace to deliver all of these services with one coordinated team, in a more efficient fashion, and under the banner of a trusted global law firm,” he added.
“With this new foray, Paul Hastings presents clients a unique opportunity not previously available in the market,” said D’Avella. “We’re bringing together some of the best legal prowess and consulting acumen to help our clients navigate new opportunities and tackle their biggest challenges, all under one roof,” he added.
The firm is actively hiring the new team. For more information please visit the Paul Hastings Career page here.
For nearly 20 years, D’Avella has assisted global life science companies with program delivery related to compliance and regulatory risks. He possesses deep expertise in risk management activities related to patient services, sales and marketing, medical affairs, and clinical operations. D’Avella has specialized in helping clients navigate complex enterprise-wide projects related to Commercial, Medical, and R&D operations and compliance, especially within the areas of legal and compliance program design, operating model development and implementation, clinical program management (including RWE study execution), monitoring program design and execution, Corporate Integrity Agreement (CIA) support, and Fair Market Value (FMV) assessments. BJ has led the creation and development of technology-enabled services and data-enabled monitoring tools.
Paul Hastings’ interdisciplinary Life Sciences and Healthcare practice helps clients protect and enhance their value. The practice has partnered with more than half of the top 50 life sciences companies by market capitalization on high-stakes litigation, multi-faceted government compliance, investigations and enforcement issues, and complex cross-border transactions.
At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.